Skip to content

Prezista (darunavir) approved for treatment-experienced patients in Europe

HIV treatment may need to start above 300 CD4s in HIV/hepatitis C coinfected, study suggests

HIV vaccine trials: measurements may overestimate participant understanding

Siblings of HIV/HCV coinfected patients also have higher mortality risk

HIV-positive women often infected with multiple HPV subtypes

Two circumcision studies halted after circumcised men's HIV risk halved

Malaria treatment compromised by suppressed immunity in HIV-positive adults

Gilead grants royalty-free licenses for tenofovir use in microbicides

Hormonal contraception does not increase HIV infection risk